# Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer

> **NCT03199144** · PHASE2 · WITHDRAWN · sponsor: **Centre Francois Baclesse, Luxembourg**

## Conditions studied

- Pancreatic Neoplasms

## Interventions

- **DRUG:** Chemotherapy
- **RADIATION:** Stereotactic radiotherapy
- **PROCEDURE:** Surgery

## Key facts

- **NCT ID:** NCT03199144
- **Lead sponsor:** Centre Francois Baclesse, Luxembourg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-04-20
- **Primary completion:** 2021-03-19
- **Final completion:** 2021-03-19
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** difficulties to recruit patients
- **Last updated:** 2022-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03199144

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03199144, "Neoadjuvant Chemotherapy and Stereotactic Radiosurgery to Pancreatectomy for Patients With Borderline Resectable Pancreatic Cancer". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03199144. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*